Henry Schein, Inc. (HSIC)
Nasdaq · Healthcare · Medical Distribution
$84.23−0.77%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $9.4B
- P/E (trailing)
- 24.6
- Forward P/E
- 14.1
- 52-week range
- $61.95 – $92.18
- 52-week change
- +30.83%
- EPS (trailing)
- $3.43
- Analyst rating
- 2.4 Buy
- Next earnings
- Nov 3, 2026
Fiscal year to Dec 2025
- Revenue
- $13.2B (+4.03%)
- Net income
- $419M
- Operating margin
- 5.0%
- Diluted EPS
- $3.27
- Free cash flow
- $573M
From the company’s annual report on SEC EDGAR.
About Henry Schein, Inc.
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand.
Headquarters: Melville, United States · 25,000 employees · henryschein.com